Overview

D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will examine the effectiveness of D-serine in increasing and sustaining the benefits of cognitive retraining in people with schizophrenia.
Phase:
Phase 3
Details
Lead Sponsor:
Yale University
Collaborators:
Donaghue Foundation
Stanley Medical Research Institute
US Department of Veterans Affairs
VA Office of Research and Development